The procedure was supposed to improve the pigmentation. Instead, the treated area is darker than it was before.
That outcome is not rare. Post-inflammatory hyperpigmentation after cosmetic procedures is one of the most documented complications in dermatology. It can follow laser treatment, IPL, chemical peels, microneedling, and dermabrasion. It does not mean the procedure was performed badly. It means the skin's inflammatory response to controlled injury triggered the same melanocyte overproduction that causes any other form of PIH, except in this case, the trigger was the treatment itself.
Understanding why it happens and how it differs from normal post-treatment healing is the first step toward managing it. For some people, especially those with melanin-rich skin, it is also the most important factor to address before a procedure is booked.
Normal Darkening vs True PIH
Not all post-procedure darkening is a problem. Distinguishing between the two prevents unnecessary panic and unnecessary treatment.
Temporary post-treatment darkening is part of the normal wound-healing response. After laser or IPL, treated pigmented spots often darken and form micro-crusts over the first 3 to 7 days. After a chemical peel, the skin may appear temporarily darker or more uneven as the outer layers shed. After microneedling, redness and mild discolouration can persist for days to weeks depending on depth. This is the skin processing the controlled injury. It resolves on its own as the tissue heals.
True post-inflammatory hyperpigmentation is new pigmentation that appears in the weeks following the procedure, typically becoming visible 2 to 6 weeks after treatment. It does not look like the treated spot darkening and crusting. It looks like new, diffuse darkening in or around the treated area, sometimes extending beyond the original treatment zone. It persists. It does not resolve with the same timeline as normal healing.
The difference matters because the responses are different. Normal darkening requires patience and standard aftercare. True PIH requires active treatment and, critically, a reassessment of whether the procedure should be repeated.
If you are unsure which you are seeing, a follow-up with the treating provider is the right next step. A Wood's lamp examination can help determine the depth and nature of the pigmentation.
Why Procedures Trigger Pigmentation
Every cosmetic procedure that improves pigmentation works by creating controlled injury. That injury triggers the skin's wound-healing response, and the response is where the risk lives.
The sequence is consistent across procedure types. Tissue damage activates an inflammatory response. Inflammatory mediators, including prostaglandins, leukotrienes, and reactive oxygen species, flood the treated area. Those mediators stimulate melanocytes. The stimulated melanocytes produce excess melanin. The melanin is deposited in the surrounding keratinocytes, and the result is visible darkening.
In most skin, this response is proportionate. The inflammation resolves, the excess melanin clears over weeks, and the treated area improves.
In some skin, the response is disproportionate. The melanocytes overreact. The pigment produced exceeds what the healing process can clear. The darkening persists and becomes true PIH.
Three factors determine how likely that disproportionate response is.
Depth of injury. The deeper the procedural injury, the more intense the inflammatory response, and the more melanocyte stimulation occurs. An ablative laser creates deeper injury than a non-ablative one. A medium-depth peel penetrates further than a superficial one. Aggressive microneedling at 2.0mm provokes more inflammation than conservative treatment at 0.5mm. The relationship between depth and PIH risk is direct.
Energy and heat. Energy-based devices (lasers, IPL) deliver thermal injury in addition to mechanical disruption. Heat itself stimulates melanocytes through pathways independent of the wound-healing response. This is why laser and IPL carry higher PIH risk than procedures of comparable depth that do not involve thermal energy. A superficial chemical peel and a non-ablative laser may cause similar levels of tissue disruption, but the laser adds a thermal stimulus that the peel does not.
Baseline melanocyte reactivity. Melanocytes in darker skin tones are more numerous and more responsive to inflammatory signals. The same procedure, at the same settings, in the same hands, produces a stronger pigment response in melanin-rich skin than in lighter skin. This is not a flaw in the procedure or the skin. It is the biology of how many melanocytes are packed into the area and how reactive they are, and it needs to be factored into every procedural decision.
Risk by Procedure Type
Not all procedures carry equal PIH risk. The hierarchy matters for treatment planning, especially in pigment-prone skin.
Q-switched and picosecond lasers target melanin directly with high-intensity light pulses. They are effective for defined pigmented lesions but carry meaningful PIH risk because the energy absorption is concentrated in melanin-rich tissue. In darker skin tones (Fitzpatrick IV to VI), the competitive absorption of laser energy by epidermal melanin increases the risk of collateral thermal damage and subsequent PIH. Specific wavelengths (1064nm Nd:YAG) are safer for darker skin because they penetrate deeper and are absorbed less by epidermal melanin, but the risk is never zero.
Fractional lasers distribute energy across a grid pattern, leaving untreated tissue between micro-columns of injury. This reduces total inflammatory burden compared to fully ablative lasers. PIH risk is lower but still present, particularly with aggressive settings or in melanin-rich skin. Non-ablative fractional lasers carry less risk than ablative fractional lasers.
IPL delivers broad-spectrum light across a wider treatment area. It is less precise than laser for individual spots. The broad energy delivery means more skin surface is exposed to thermal stimulus, which can increase PIH risk over a larger area. IPL is generally considered higher risk than laser for darker skin tones because the broad wavelength range is harder to calibrate away from epidermal melanin absorption.
Chemical peels carry lower PIH risk than energy-based devices at equivalent treatment depth because they do not add thermal injury. Superficial peels (glycolic, lactic, mandelic) are the safest procedural option across skin tones. Medium-depth peels (TCA, Jessner's) carry moderate PIH risk, concentrated in the first 2 to 4 weeks post-treatment. Deep peels carry significant risk and are rarely used for pigmentation in darker skin tones.
Microneedling creates mechanical micro-injuries without targeting melanin and without delivering thermal energy. This gives it a favourable PIH risk profile across skin tones. The risk increases with needle depth, with aggressive depths (1.5mm+) and excessive passes producing more inflammation. When combined with topical depigmenting agents, microneedling can be both a treatment and a delivery mechanism.
Dermabrasion involves mechanical removal of the outer skin layers. It carries moderate to high PIH risk depending on depth and is less commonly used for pigmentation than the options above. The risk is highest in melanin-rich skin and when performed aggressively.
For detail on how laser and peels compare overall, see Laser vs Chemical Peels.
The Skin Tone Factor
Darker skin tones (Fitzpatrick IV to VI) are at higher risk for post-procedure PIH. This is the single most important variable in procedural risk assessment for pigmentation.
The reason is biological, not circumstantial. Melanocytes in darker skin are more numerous, more active at baseline, and more responsive to inflammatory stimulation. The inflammatory response triggered by a procedure produces a stronger pigment output in melanin-rich skin than in lighter skin, even when the procedure is identical.
This does not mean procedures are unsafe for darker skin tones. It means the selection of procedure, the device settings, the number of passes, and the experience of the provider with melanin-rich skin all carry more weight. A provider who uses conservative settings, who conducts test patches before full treatment, who adjusts parameters based on the skin's early response, and who monitors closely for the first signs of PIH is not being overcautious. That provider is practicing standard of care for this skin type.
The safest procedural options for Fitzpatrick IV to VI skin are superficial chemical peels and conservative microneedling. Laser and IPL are not ruled out, but the risk-benefit calculation is narrower and the consequence of getting the settings wrong is a problem that is harder to resolve than the one the procedure was meant to treat.
Prevention: Before the Procedure
The most effective treatment for post-procedure PIH is preventing it. Several pre-treatment strategies reduce the risk meaningfully.
Topical preparation. A 2 to 4 week course of a tyrosinase inhibitor (vitamin C, hydroquinone at prescription strength if appropriate, or tranexamic acid) before the procedure suppresses melanocyte activity in the treatment area. This lowers the baseline reactivity of the melanocytes before they are provoked by the procedural injury. Many dermatologists consider this standard protocol, particularly for patients with darker skin tones or a history of PIH.
Sun protection. The treatment area should have minimal recent UV exposure before the procedure. Tanned or recently sun-exposed skin has more active melanocytes, which increases PIH risk. Strict sun protection for at least 2 to 4 weeks before the procedure reduces that baseline activity.
Test patches. For laser and IPL in melanin-rich skin, a test patch in an inconspicuous area allows the provider to assess the skin's response to specific settings before treating the full area. This is not always done. It should be.
Realistic settings. Conservative parameters (lower fluence, fewer passes, longer pulse durations) produce less inflammatory provocation. For pigmentation treatment in at-risk skin, the provider who starts conservative and escalates cautiously over multiple sessions produces better long-term outcomes than the provider who tries to clear everything in one aggressive session.
Treatment: When PIH Develops
If post-procedure PIH has already developed, the management approach is the same as for any other PIH, but with one additional consideration: the skin has recently been through a procedural injury and may still be in a sensitised state.
Wait for full healing before introducing actives. The skin barrier needs to be intact before brightening products are applied. Introducing tyrosinase inhibitors or exfoliants onto skin that is still healing from a procedure risks compounding the inflammation. Most providers recommend waiting 2 to 4 weeks after a peel, 4 to 6 weeks after laser or IPL, and 2 to 4 weeks after microneedling before starting active treatment. Follow your provider's specific guidance.
Start with gentle tyrosinase inhibition. Vitamin C, tranexamic acid, or niacinamide are the lowest-risk starting point. They suppress melanin production without the irritation burden of exfoliants or retinoids. Niacinamide is particularly useful here because it also supports barrier repair.
Add retinoids gradually. Once the skin has tolerated a tyrosinase inhibitor for 2 to 4 weeks without irritation, a low-concentration retinol (0.25%, two to three nights a week) can be introduced to accelerate turnover of the pigmented cells. Build slowly.
Sun protection is non-negotiable. Post-procedure skin is more vulnerable to UV. Melanocytes that have been stimulated by procedural inflammation are primed to overproduce in response to UV exposure. Broad-spectrum SPF 30 or higher, daily, reapplied with exposure. Iron oxide-tinted sunscreen is worth considering for visible light protection.
Prescription escalation if needed. If PIH persists beyond 3 to 6 months of consistent topical treatment, prescription-strength tretinoin, azelaic acid, or hydroquinone can push through the plateau. A superficial peel series may also help, though the decision to perform another procedure on skin that developed PIH from a procedure requires careful discussion with the provider.
Do not repeat the original procedure without reassessment. If a laser session caused PIH, repeating the same laser at the same settings will likely cause it again. The approach needs to change: different settings, different wavelength, different procedure entirely, or a longer topical preparation phase before any re-treatment. This conversation with the treating dermatologist is essential.
For the full treatment framework for PIH, see How to Treat Post-Inflammatory Hyperpigmentation.
The Internal Factor
Post-procedure PIH is, by definition, an inflammatory event. The procedure creates controlled injury. The injury triggers inflammatory mediators. The mediators stimulate melanocytes. How strongly those melanocytes respond, and how efficiently the skin resolves the inflammation afterward, is influenced by systemic factors that the procedure and the aftercare do not reach.
Antioxidant capacity, inflammatory regulation, and the nutrients required for tissue repair and cellular turnover all influence the skin's response to procedural injury. Supporting those processes internally does not replace sun protection or topical aftercare. It can complement both, particularly in skin that is prone to disproportionate pigment responses.
Hyperpigmentation from within covers those pathways in detail.
The Takeaway
Post-procedure hyperpigmentation is a known, documented risk of every procedure used to treat pigmentation. It is not a sign that the procedure was wrong or the provider was negligent. It is the skin's inflammatory response overshooting, and it is more likely in melanin-rich skin, with deeper injury, and with thermal energy.
Prevention matters more than treatment. Topical preparation, sun protection, conservative settings, test patches, and a provider experienced with the patient's skin type are what reduce the risk before it materialises. When PIH does develop, the management is patient, gentle, and sequential: let the skin heal, then suppress, then accelerate turnover, and protect throughout.
The most important decision is the one made before the procedure. Choosing the right procedure, at the right settings, with the right provider, after the right preparation, is the best treatment for post-procedure PIH there is.
